| Market Capitalization (Millions $) |
335 |
| Shares
Outstanding (Millions) |
55 |
| Employees |
495 |
| Revenues (TTM) (Millions $) |
143 |
| Net Income (TTM) (Millions $) |
8 |
| Cash Flow (TTM) (Millions $) |
34 |
| Capital Exp. (TTM) (Millions $) |
0 |
Kamada Ltd
Kamada Ltd is a biopharmaceutical company that operates in the fields of plasma-derived proteins and immunoglobulins for various medical conditions. The company has over thirty years of experience in the development and commercialization of innovative therapeutics for patients with rare and chronic diseases.
Founded in 1990, Kamada Ltd is headquartered in Rehovot, Israel, and has additional offices and facilities in the United States, Germany, and the United Kingdom. The company has a global network of distributors and partners, enabling it to market its products to medical professionals worldwide.
Kamada Ltd is dedicated to developing therapeutic products to treat a variety of life-threatening conditions, including bleeding disorders, immunodeficiency diseases, pulmonary arterial hypertension, and other medical conditions that require specific proteins and enzymes for treatment. They offer a comprehensive range of products, including Alpha1- Antitrypsin, Immunoglobulin, Coagulation Factors, and other related products.
The company's flagship product, Glassia, is an FDA-approved Alpha1-Proteinase Inhibitor that is used to treat genetic emphysema, a life-threatening condition that affects the lungs. In addition, Kamada Ltd also offers a range of coagulation factors, which are essential for the effective treatment of Bleeding Disorders.
One of Kamada Ltd's significant strengths is its ability to control the entire manufacturing process, from start to finish, to ensure the highest quality and consistency of its products. The company employs a team of dedicated specialists and scientists who use state-of-the-art scientific equipment and technology to develop and manufacture its products.
In addition to its product development activities, Kamada Ltd also offers research and development services to other pharmaceutical companies. The company has a research and development team that is focused on developing innovative and effective treatments for various medical conditions. The company also operates a clinical trial division that conducts comprehensive clinical trials to test the safety and efficacy of its products.
In conclusion, Kamada Ltd is an innovative and reliable biopharmaceutical company that provides high-quality plasma-derived products and immunoglobulins to patients worldwide. The company's commitment to research and development, quality control, and customer service has enabled it to become a leader in the field of biopharmaceuticals.
Company Address: 2 Holzman St Rehovot 7670402
Company Phone Number: 8 9406472 Stock Exchange / Ticker: NASDAQ KMDA
|
0.000%
1.82%